LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi
(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday: Read More
| Price | 1,882.00p on 06-05-2026 at 10:35:02 |
|---|---|
| Change | 25.00p 1.35% |
| Buy | 1,882.50p |
| Sell | 1,881.50p |
| Last Trade: | Buy 23.00 at 1,882.00p |
| Day's Volume: | 730,465 |
| Last Close: | 1,857.00p |
| Open: | 1,870.50p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,865.50p - 1,889.50p |
| 52wk Range: | 1,315.00p - 2,282.00p |
| Market Capitalisation: | £75.56b |
| VWAP: | 1,878.268p |
| Shares in Issue: | 4.02b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 23 | 1,882.00p | Automatic Execution |
11:35:02 - 06-May-26 |
| Buy* | 19 | 1,882.00p | Automatic Execution |
11:35:02 - 06-May-26 |
| Buy* | 374 | 1,882.00p | Automatic Execution |
11:35:02 - 06-May-26 |
| Buy* | 70 | 1,882.00p | Automatic Execution |
11:35:02 - 06-May-26 |
| Buy* | 1,000 | 1,881.69p | Ordinary |
11:34:47 - 06-May-26 |
| Buy* | 15 | 1,881.50p | SI Trade |
11:34:43 - 06-May-26 |
| Sell* | 679 | 1,881.50p | Automatic Execution |
11:34:28 - 06-May-26 |
| Unknown* | 195 | 1,881.75p | SI Trade |
11:34:26 - 06-May-26 |
| Buy* | 24 | 1,882.6371p | Ordinary |
11:34:23 - 06-May-26 |
| Sell* | 77 | 1,882.50p | Automatic Execution |
11:34:18 - 06-May-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 1st May 2026 3:00 pm | RNS | Holding(s) in Company |
| 1st May 2026 3:00 pm | RNS | Total Voting Rights |
| 29th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 29th Apr 2026 7:00 am | RNS | 1st Quarter Results |
| 28th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 28th Apr 2026 7:00 am | RNS | Bepirovirsen priority review US filing acceptance |
| 27th Apr 2026 12:00 pm | RNS | Efimosfermin granted US/EU regulatory designations |
| 27th Apr 2026 7:00 am | RNS | TESARO update on AnaptysBio Inc. litigation |
| 24th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |